medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. Headquartered in Cincinnati, Ohio, the company operates with a unique, fully integrated model that emphasizes therapeutic expertise and operational efficiency. Unlike traditional CROs, Medpace employs a physician-led approach, ensuring that medical and scientific experts are deeply involved in study design and execution from start to finish. This methodology allows for streamlined clinical trials, higher quality data, and faster regulatory timelines for sponsors.

The company offers a comprehensive suite of services, including medical affairs, clinical trial management, life science consulting, and regulatory affairs. Medpace also maintains its own central laboratories, bioanalytical laboratories, imaging core labs, and a clinical pharmacology unit, enabling seamless coordination of complex trials. With a global footprint spanning North America, Europe, Asia-Pacific, and Latin America, Medpace supports the development of safe and effective medical therapeutics across a wide range of therapeutic areas, such as oncology, cardiology, metabolic disease, and infectious diseases. The organization is dedicated to accelerating the global development of innovative medical treatments through its disciplined, high-science operating model.